Evidence map›Paper›PMID 27914931›Full record

ArticleVirus research2017

Valosin-containing protein (VCP/p97) plays a role in the replication of West Nile virus.

Wallaya Phongphaew, Shintaro Kobayashi, Michihito Sasaki, Michael Carr, William W Hall, Yasuko Orba, Hirofumi Sawa

Open access · greenAbstract read
In one paragraph

Article in Virus research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Identification of NMS-873, an allosteric and specific p97 inhibitor, as a broad antiviral against both influenza A and B viruses.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Wallaya PhongphaewDivision of Molecular Pathobiology, Research Center for Zoonosis Control, Hokkaido University, N20, W10, Kita-ku, Sapporo 001-0020, Japan.
Shintaro KobayashiDivision of Molecular Pathobiology, Research Center for Zoonosis Control, Hokkaido University, N20, W10, Kita-ku, Sapporo 001-0020, Japan; Laboratory of Public Health, Graduate School of Veterinary Medicine, Hokkaido University, N18, W9, Kita-ku, Sapporo 001-0020, Japan.
Michihito SasakiDivision of Molecular Pathobiology, Research Center for Zoonosis Control, Hokkaido University, N20, W10, Kita-ku, Sapporo 001-0020, Japan.
Michael CarrGlobal Institution for Collaborative Researches and Education (GI-CoRE), Global Station for Zoonosis Control, Hokkaido University, N20, W10, Kita-ku, Sapporo 001-0020, Japan; National Virus Reference Laboratory, University College Dublin, Belfield, Dublin 4, Ireland.
William W HallGlobal Institution for Collaborative Researches and Education (GI-CoRE), Global Station for Zoonosis Control, Hokkaido University, N20, W10, Kita-ku, Sapporo 001-0020, Japan; Center for Research in Infectious Diseases, University College of Dublin, Belfield, Dublin 4, Dublin, Ireland; Global Virus Network (GVN), The Institute of Human Virology, University of Maryland, 22S. Greene Street, Baltimore, MD 21201, USA.
Yasuko OrbaDivision of Molecular Pathobiology, Research Center for Zoonosis Control, Hokkaido University, N20, W10, Kita-ku, Sapporo 001-0020, Japan.
Hirofumi SawaDivision of Molecular Pathobiology, Research Center for Zoonosis Control, Hokkaido University, N20, W10, Kita-ku, Sapporo 001-0020, Japan; Global Institution for Collaborative Researches and Education (GI-CoRE), Global Station for Zoonosis Control, Hokkaido University, N20, W10, Kita-ku, Sapporo 001-0020, Japan; Global Virus Network (GVN), The Institute of Human Virology, University of Maryland, 22S. Greene Street, Baltimore, MD 21201, USA. Electronic address: h-sawa@czc.hokudai.ac.jp.
Hokkaido University · JPUniversity College Dublin · IE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Valosin-containing protein (VCP) is classified as a member of the type II AAA

Indexed as

Virus ReplicationCell LineEnzyme InhibitorsGene Knockdown TechniquesGenome, ViralHumansRNA InterferenceRNA, ViralValosin Containing ProteinWest Nile FeverWest Nile virusEnzyme InhibitorsRNA, ViralValosin Containing ProteinEarly stepsGenome replicationVCPWNV replication

Identifiers

PMID27914931
PMCPMC7114552
OpenAlexW2558678148

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.